skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi
Is this worth a trade presently at .05.

Thank you
Read Answer Asked by Mike on September 19, 2018
Q: hi Peter if the 100 million contact with the Saudi's is lost say TODAY what is the material affect to COV.? ie. 1. what would be the new revised P/E ratio? and. 2. what is your best guess as to the new lower trading price per share ? 3. does your forecast of 35 cents to 40cents per share for 2019 assume a favourable resolution of this issue? 4. what percent of equity is currently owned by executives and insiders? thanks Richard
Read Answer Asked by richard on September 19, 2018
Q: Good Morning 5i Do you have any idea as to why Tilray is rising so fast? I'm holding long on Canopy for this sector and not intending to sell this year. And not intending to buy Tilray. Is Tilray's rise likely to pull upward sp of WEED up faster? Also talk of large short positions in the sector. Any background thoughts on what is happening as we approach Oct. 17th. ?
Read Answer Asked by Randy on September 19, 2018
Q: I have set 8% sector target and have invested 50% - GUD 15% of total target, TD Health Sciences 11%, and 9% each to ISRG, ILMN, and COV.
If I drop TD Fund, then 60% available to reinvest - what names and allocations do you advise?
Thx for your excellent advice,
Sam
Read Answer Asked by sam on September 19, 2018
Q: Good morning...my financials listed above make up 12.8% of my portfolio. (TD 3.8, BNS, 3.3, SLF 3.1 and GS 2.6)..I was looking at changing it up a bit and selling GS and adding to either TD, BNS or SLF..dividend not a big concern...looking for a bit more growth potential in the Financials...what do you think? or other alternative..
Thanks
Read Answer Asked by Matthew on September 19, 2018
Q: Hi, I'm a new subscriber and am really benefitting from the Qs and As you post.

I was wondering if you have any insight on Optiva (previously Redknee). I bought it in 2015 and am wondering if I should bite the bullet and sell.

Also, any thoughts on starting a small position in Blackberry as a growth stock in my TFSA?

Thank you.
Read Answer Asked by Valencia on September 19, 2018
Q: You have mentioned that you dislike companies that tend to put out too many press releases. I own Reliq Health Technologies and am often surprised at what they consider worth communicating. The other day the press release headline was "Reliq Health Technologies receives second hardware shipment". Today they put out " Reliq Health Technologies Kick Off Patient Onboarding at Rio Grande Valley Health Alliance in Texas". I'm not sure that these qualify as huge milestones that the public and shareholders really need to know and they seem to be self-promotional. Would you consider RHT as a company that does too much self-promoting and does it cause you any concern?
Read Answer Asked by Steven on September 19, 2018
Q: I have never liked the "bought deal" type financings that seem to be the way things are done in Canada, but I have to admit that as a holder of DOO watching the steep sell-off after the recent secondary offering priced in US$ was no fun. TD was offering the shares to clients with the price "TBD within the context of the market". The shares dropped about 15% in the days following the announcement when the issue was priced. Can you briefly explain how the pricing is determined for offerings such as this one. Do they simply wait for the market reaction and then set the price where the shares end up on the pricing date? What are the sellers and buyers obligations? Can the sellers just change their mind if the market reacts too harshly and say "thanks but no thanks, we will keep our holdings rather than sell at a 15% discount?
Read Answer Asked by Steven on September 19, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!